Efficacy, safety and prognostic benefit of intravenous iron therapy with ferric carboxymaltose in patients with heart failure and left ventricular dysfunction

Int J Cardiol. 2016 Jan 1:202:118-20. doi: 10.1016/j.ijcard.2015.08.204. Epub 2015 Sep 1.
No abstract available

Keywords: Anaemia; Cardiovascular safety; Ferric carboxymaltose; Functional outcome; Intravenous iron; Iron deficiency.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anemia, Iron-Deficiency / blood
  • Anemia, Iron-Deficiency / diagnosis
  • Anemia, Iron-Deficiency / drug therapy*
  • Female
  • Ferric Compounds / administration & dosage*
  • Ferric Compounds / adverse effects
  • Follow-Up Studies
  • Heart Failure / blood
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Humans
  • Infusions, Intravenous
  • Male
  • Maltose / administration & dosage
  • Maltose / adverse effects
  • Maltose / analogs & derivatives*
  • Middle Aged
  • Prognosis
  • Treatment Outcome
  • Ventricular Dysfunction, Left / blood
  • Ventricular Dysfunction, Left / diagnosis
  • Ventricular Dysfunction, Left / drug therapy*

Substances

  • Ferric Compounds
  • ferric carboxymaltose
  • Maltose